Registered entities
Visus Therapeutics, Inc.
Reg. No. 84-3379554United States
VisuS
Reg. No. 40103598890Latvia
Innovation
11 patent families (3 granted) — focus: Human necessities, Chemistry & metallurgy; filing pace steady. Cited 150 times.
| Year | Filings |
|---|---|
| 2020 | 3 |
| 2021 | 2 |
| 2022 | 3 |
| 2023 | 9 |
| 2024 | 4 |
| 2025 | 5 |
| 2026 | 3 |
Social engagement
Social engagement: 12.1K social following, 9 posts in the last 12 months — around the industry typical range.
Investor mix
8 investors on record; lead investors include RTW Investments, Johnson & Johnson Innovation, Life Sciences Partners, Sage.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 2 | 25% |
| Private equity | 3 | 38% |
| Angel & family office | 1 | 13% |
| Other / undisclosed | 2 | 25% |
Hiring activity
Hires occasionally
1 role tracked across 1 of the last 12 months
7 Mar 2026 · Specialty Sales Manager (Long Beach) · Long Beach
Based on job postings tracked across public sources.
Recent activity
19 May 2026
Product launch
YUVEZZITM (carbachol and brimonidine tartrate ophthalmic solution)